ACTRN12624000032550尚未招募3 期
The effect of ertugliflozin on liver function in patients with nonalcoholic fatty liver disease (NAFLD) associated with type 2 diabetes mellitus.
Abdul Wali Khan University0 个研究点目标入组 180 人开始时间: 2024年1月15日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Participants for this RCT must be Adult patients (above age of 20 years), diagnosed with non alcoholic fatty liver diseases along with type 2 diabetes mellitus.
排除标准
- •Participants not having non alcoholic fatty liver diseases along with type 2 diabetes mellitus., not willing to participate and the patient having elevated liver enzyme with any other risk factor such as hepatitis.
研究者
相似试验
招募中
3 期
Effect of Empagliflozin in diabetic patients with non-alcoholic steatohepatitisnon-alcoholic steatohepatitis.Nonalcoholic steatohepatitis (NASH)K75.81IRCT20210609051526N2Babol University of Medical Sciences110
招募中
4 期
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLDLiver FatLiver FibrosisGlycemic ControlBody Weight ChangesWaist CircumferenceToleranceNCT05644717Getz Pharma164
招募中
不适用
Effect of erobixibat on liver dysfunction in patients with chronic constipatioiver dysfuncitonJPRN-UMIN000039833Osaka Medical College20
招募中
3 期
Effect of oral livergol on liver enzymes in patients with LeukemiaC95.9eukemia in the Preservative Phase.Leukemia, unspecifiedIRCT20150119020715N10Arak University of Medical Sciences40
已完成
4 期
Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 DiabetesNon-alcoholic Fatty Liver DiseaseType 2 DiabetesNCT02637973The Deutsche Diabetes Forschungsgesellschaft e.V.84